FDA Heads Back to Work, for Now

News
Article

The latest continuing resolution funds the government for three weeks.

After a three-day government shutdown due to a budget stalemate in Congress, FDA and other government employees resumed work on Jan. 23, 2018. On Monday, Jan. 22, approximately 40% of the FDA staff was furloughed due to the lack of funding for operations.

On Jan. 22, Congress approved, and President Trump signed, a continuing resolution that will fund the government through Feb. 8, 2018. Congress also funded the Children’s Health Insurance Program for six years and delayed taxes on medical device sales.

The funding extension was enacted after Senate leadership agreed to address the future of the Deferred Action for Childhood Arrivals (DACA) program, a program for people brought to the United States as minors, that is central to contentious debate to the nation’s immigration policy.

The Congress and the administration have three weeks to agree on funding for the government for the 2018 fiscal year, and to discuss DACA.

 

Recent Videos
Roger Viney from ICE Pharma discusses the quality and compliance issues surrounding the use of animal-derived ingredients in the bio/pharma industry.
Tore Bergsteiner from MAIN5 discusses the most pertinent and impactful bio/pharma industry trends from 2024.
Simon Wright from Almac Pharma Services chats about shifting demand for commercial manufacturing services and how service providers are adapting to meet demand.
Ian Lafferty from Upperton discusses the trends and challenges facing sterile manufacturing and how partnering with CDMOs can help innovators progress to the market.
Miguel Forte from ISCT and Kiji Therapeutics talks about the potential impact of a changing European political landscape.
Miguel Forte from ISCT and Kiji Therapeutics provides his insights into the changing political landscape in the US as well as legislative and regulatory adjustments
Miguel Forte from ISCT and Kiji Therapeutics chats about expectations for 2025 and the future technology agenda for industry.